口腔前恶性疾病的恶性转变率:一个大型数据库分析
Andrew Meci1, Neerav Goyal1,2, David Goldenberg1,2
1The Pennsylvania State University College of Medicine, Hershey, Pennsylvania, USA.
The Laryngoscope
|May 10, 2025
概括
口腔白血病 (OL),口腔平坦菌 (OLP) 和口腔下粘膜纤维化 (OSF) 的恶性转化率比以前认为的更高,转化为口腔状细胞癌 (OSCC). 这些发现强调了对口腔前性疾病 (OPMD) 进行警监测和及时干预的关键需求.
科学领域:
- 口腔病理学 口腔病理学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 口腔白血病 (OL),口腔平坦菌 (OLP) 和口腔下粘膜纤维化 (OSF) 是已知的癌前口腔前恶性疾病 (OPMD).
- 以前估计的恶性转化率到口腔状细胞癌 (OSCC) 是基于有限的数据.
- 这项研究提供了迄今为止对OPMD恶性转变率的最大分析.
研究的目的:
- 确定OL,OLP和OSF到OSCC的5年恶性转化率.
- 为了将这些率与对照队列进行比较.
- 分析OPMD患者的治疗途径和生存结果.
主要方法:
- 使用TriNetX数据库进行回顾性队列研究.
- 包括在2008-2018年间被诊断患有OL,OLP或OSF的18岁以上的患者.
- 对OSCC转变,治疗和生存的5年随访数据的分析.
主要成果:
- 总共包括了59,204名患者.
- 五年恶性转变率为OL的15.6%,OLP的1.4%,OSF的18.6%.
- OPMD的整体5年恶性转变率为6.2%,明显高于对照组 (p < 0.01).
结论:
- 对OL,OLP和OSF的恶性转变率高于之前报告的水平.
- 对OL和OSF的高转化率需要密切监测患者和及时治疗.
- 患有OPMD的患者的5年生存概率为94.3%.
相关概念视频
Tumor Progression
6.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.1K
Cancers Originate from Somatic Mutations in a Single Cell
11.3K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.3K
Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
Cancer
47.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.1K
Skin Cancer
2.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
2.9K
Mutagenicity and Carcinogenicity
1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K


